Skip to content

Author

Samuel Adamsson Eryd

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Personalized evaluation of NT-proBNP and clinical characteristics in suspected heart failure: the PRECISE-HF study.

BACKGROUND AND AIMS N-terminal pro-B-type natriuretic peptide (NT-proBNP) is recommended to guide echocardiography referral in community-based patients with suspected heart failure (HF), but diagnostic performance is influenced by individual characteristics including age, ethnicity, kidney function, cardiac rhythm, and...

K. Docherty, B. Heywood, L. Anderson et al. · 0 citations
Open access Sep 2026

Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom

Background Sodium–glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin has shown favourable outcomes in trials for heart failure with reduced ejection fraction (HFrEF), but little is known about real-world prescribing practices, tolerability, or impact on patient quality of life (QoL) in the United Kingdom. Methods...

Steven Coombs, Angela Tithecott, C. Thiebaud et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.